The regulator upheld the merger of Scheme A with larger asset classes citing its small corpus and concentration risk. The move improves diversification, stability, and long-term retirement outcomes ...
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback